These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32956824)

  • 1. Combination of metformin and genistein alleviates non-alcoholic fatty liver disease in high-fat diet-fed mice.
    Zamani-Garmsiri F; Hashemnia SMR; Shabani M; Bagherieh M; Emamgholipour S; Meshkani R
    J Nutr Biochem; 2021 Jan; 87():108505. PubMed ID: 32956824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high-fat diet fed mice.
    Zamani-Garmsiri F; Ghasempour G; Aliabadi M; Hashemnia SMR; Emamgholipour S; Meshkani R
    IUBMB Life; 2021 Jan; 73(1):252-263. PubMed ID: 33326684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of metformin with morin alleviates hepatic steatosis via modulating hepatic lipid metabolism, hepatic inflammation, brown adipose tissue thermogenesis, and white adipose tissue browning in high-fat diet-fed mice.
    Tehrani SS; Goodarzi G; Panahi G; Zamani-Garmsiri F; Meshkani R
    Life Sci; 2023 Jun; 323():121706. PubMed ID: 37075944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin in combination with genistein ameliorates skeletal muscle inflammation in high-fat diet fed c57BL/6 mice.
    Aliabadi M; Zamani-Garmsiri F; Panahi G; Tehrani SS; Meshkani R
    Cytokine; 2021 Oct; 146():155638. PubMed ID: 34242900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of metformin and p-coumaric acid mitigates metabolic dysfunction associated with obesity and nonalcoholic fatty liver disease in high-fat diet obese C57BL/6 mice.
    Goodarzi G; Tehrani SS; Panahi G; Bahramzadeh A; Meshkani R
    J Nutr Biochem; 2023 Aug; 118():109369. PubMed ID: 37100305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein alleviates the development of nonalcoholic steatohepatitis in ApoE(-/-) mice fed a high-fat diet.
    Jeon S; Park YJ; Kwon YH
    Mol Nutr Food Res; 2014 Apr; 58(4):830-41. PubMed ID: 24214843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
    Hong Y; Choi SI; Hong E; Kim GH
    J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
    Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice.
    Inamdar S; Joshi A; Malik S; Boppana R; Ghaskadbi S
    Biochem Biophys Res Commun; 2019 Oct; 519(1):106-112. PubMed ID: 31472955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling.
    Song K; Zhang Y; Ga Q; Bai Z; Ge RL
    Life Sci; 2020 Jul; 252():117633. PubMed ID: 32289432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway.
    Chyau CC; Wang HF; Zhang WJ; Chen CC; Huang SH; Chang CC; Peng RY
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31935815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats.
    Liu H; Zhong H; Yin Y; Jiang Z
    Biomed Pharmacother; 2017 Jul; 91():964-969. PubMed ID: 28514835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.
    Woo SL; Xu H; Li H; Zhao Y; Hu X; Zhao J; Guo X; Guo T; Botchlett R; Qi T; Pei Y; Zheng J; Xu Y; An X; Chen L; Chen L; Li Q; Xiao X; Huo Y; Wu C
    PLoS One; 2014; 9(3):e91111. PubMed ID: 24638078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
    Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
    Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.
    Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA
    Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
    Lin CH; Kuo YH; Shih CC
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
    Dwivedi DK; Jena GB
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
    Zhou ST; Cui W; Kong L; Yang X
    Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice.
    Munkong N; Somnuk S; Jantarach N; Ruxsanawet K; Nuntaboon P; Kanjoo V; Yoysungnoen B
    Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.